Potential Adverse Effects of Resveratrol: A Literature Review
Authors:
- Abdullah ShaitoAbdullah Shaito
- Anna Maria PosadinoAPAnna Maria Posadino
- Nadin YounesNYNadin Younes
- Hiba HasanHHHiba Hasan
- Sarah HalabiSHSarah Halabi
- Dalal AlhababiDADalal Alhababi
- Anjud Al-MohannadiAAAnjud Al-Mohannadi
- Wael M Abdel-RahmanWAWael M Abdel-Rahman
- Ali H. EidAEAli H. Eid
- Gheyath K. NasrallahGheyath K. Nasrallah
- Gianfranco PintusGianfranco Pintus
Top Cited Papers
Open Access
- 18 March 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (6) , 2084
Abstract
Due to its health benefits, resveratrol (RE) is one of the most researched natural polyphenols. Resveratrol’s health benefits were first highlighted in the early 1990s in the French paradox study, which opened extensive research activity into this compound. Ever since, several pharmacological activities including antioxidant, anti-aging, anti-inflammatory, anti-cancerous, anti-diabetic, cardioprotective, and neuroprotective properties, were attributed to RE. However, results from the available human clinical trials were controversial concerning the protective effects of RE against diseases and their sequelae. The reason for these conflicting findings is varied but differences in the characteristics of the enrolled patients, RE doses used, and duration of RE supplementation were proposed, at least in part, as possible causes. In particular, the optimal RE dosage capable of maximizing its health benefits without raising toxicity issues remains an area of extensive research. In this context, while there is a consistent body of literature on the protective effects of RE against diseases, there are relatively few reports investigating its possible toxicity. Indeed, toxicity and adverse effects were reported following consumption of RE; therefore, extensive future studies on the long-term effects, as well as the in vivo adverse effects, of RE supplementation in humans are needed. Furthermore, data on the interactions of RE when combined with other therapies are still lacking, as well as results related to its absorption and bioavailability in the human body. In this review, we collect and summarize the available literature about RE toxicity and side effects. In this process, we analyze in vitro and in vivo studies that have addressed this stilbenoid. These studies suggest that RE still has an unexplored side. Finally, we discuss the new delivery methods that are being employed to overcome the low bioavailability of RE.Keywords
Funding Information
- Qatar University (IRCC#181)
This publication has 220 references indexed in Scilit:
- Different Redox Response Elicited by Naturally Occurring Antioxidants in Human Endothelial CellsThe Open Biochemistry Journal, 2013
- Resveratrol Inhibits Alpha-Melanocyte-Stimulating Hormone Signaling, Viability, and Invasiveness in Melanoma CellsEvidence-Based Complementary and Alternative Medicine, 2013
- High-throughput genotoxicity assay identifies antioxidants as inducers of DNA damage response and cell deathProceedings of the National Academy of Sciences, 2012
- Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activityFood and Chemical Toxicology, 2011
- Resveratrol directly targets COX‐2 to inhibit carcinogenesisMolecular Carcinogenesis, 2008
- Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatographyJournal of Chromatography B, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Free radicals, metals and antioxidants in oxidative stress-induced cancerChemico-Biological Interactions, 2006
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004